Viyash Scientific Ltd Faces Technical Momentum Shift Amid Bearish Signals

2 hours ago
share
Share Via
Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting growing investor caution amid recent price declines and sector headwinds.
Viyash Scientific Ltd Faces Technical Momentum Shift Amid Bearish Signals

Technical Momentum and Price Action Overview

On 24 Mar 2026, Viyash Scientific’s stock closed at ₹181.30, down 3.79% from the previous close of ₹188.45. The intraday range saw a high of ₹188.45 and a low of ₹178.40, indicating increased volatility. The stock remains significantly below its 52-week high of ₹260.30, while comfortably above its 52-week low of ₹111.00, suggesting a wide trading band over the past year.

The recent price momentum shift is reflected in the technical trend, which has deteriorated from mildly bullish to mildly bearish. This transition signals a weakening of upward price pressure and a potential increase in selling interest among traders and investors.

MACD and Momentum Indicators Signal Divergence

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD is bearish, indicating that short-term momentum is weakening relative to longer-term trends. However, the monthly MACD remains bullish, suggesting that the longer-term trend still favours upward movement, albeit with caution.

This divergence between weekly and monthly MACD readings highlights a transitional phase where short-term selling pressure is increasing, but the broader trend has not yet fully reversed. Investors should monitor this closely for confirmation of a sustained downtrend or a potential rebound.

RSI and Bollinger Bands Confirm Bearish Pressure

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum confirmation suggests that the stock is neither overbought nor oversold, leaving room for further directional movement.

Conversely, Bollinger Bands on both weekly and monthly timeframes have turned bearish. The stock price is trending towards the lower band, indicating increased volatility and a potential continuation of downward pressure. This technical setup often precedes further declines or consolidation phases.

Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!

  • - Long-term growth stock
  • - Multi-quarter performance
  • - Sustainable gains ahead

Invest for the Long Haul →

Moving Averages and KST Indicate Mixed Signals

Daily moving averages for Viyash Scientific remain mildly bullish, suggesting that short-term price averages are still supporting upward momentum. However, this is tempered by the weekly and monthly KST (Know Sure Thing) indicator readings, which are bearish and mildly bearish respectively. The KST is a momentum oscillator that helps identify major price trends, and its current readings imply that the stock’s momentum is weakening over the medium term.

Additionally, the Dow Theory analysis aligns with this view, showing mildly bearish trends on both weekly and monthly charts. This further reinforces the notion that the stock is undergoing a phase of technical correction or consolidation.

Volume and On-Balance Volume (OBV) Trends

Volume analysis reveals no clear trend on a weekly basis, with the On-Balance Volume (OBV) indicator showing no definitive direction. However, the monthly OBV is mildly bullish, indicating that despite recent price declines, there is some accumulation occurring over the longer term. This divergence between price and volume trends may suggest that institutional investors are selectively buying at current levels, providing a potential floor for the stock.

Comparative Performance Against Sensex

Viyash Scientific’s recent returns have underperformed the broader Sensex index over short to medium timeframes. Over the past week, the stock declined by 7.03%, nearly double the Sensex’s 3.72% fall. Similarly, the one-month return was -17.40% compared to the Sensex’s -12.72%. Year-to-date, the stock has fallen 12.90%, slightly better than the Sensex’s 14.70% decline.

However, over longer horizons, Viyash Scientific has delivered strong outperformance. The one-year return stands at 25.77%, significantly ahead of the Sensex’s -5.47%. Over three years, the stock has surged 146.16%, dwarfing the Sensex’s 25.50% gain. This long-term strength contrasts with recent weakness and highlights the stock’s volatility and cyclical nature.

On the downside, the five-year return is negative at -25.16%, while the Sensex gained 45.24% over the same period. The ten-year return of 10.28% also lags the Sensex’s robust 186.91% growth, reflecting periods of underperformance and sector-specific challenges.

Mojo Score and Analyst Ratings

MarketsMOJO assigns Viyash Scientific a Mojo Score of 40.0, categorising it as a Sell with a recent downgrade from Hold on 23 Mar 2026. This rating reflects the deteriorating technical parameters and cautious outlook from a fundamental perspective. The company is classified as a small-cap within the Pharmaceuticals & Biotechnology sector, which often entails higher volatility and risk.

Investors should weigh these technical signals alongside fundamental factors and sector dynamics before making investment decisions.

Why settle for Viyash Scientific Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology small-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Investor Takeaway and Outlook

Viyash Scientific Ltd’s recent technical deterioration signals caution for investors. The shift from mildly bullish to mildly bearish trends, combined with bearish weekly MACD and Bollinger Bands, suggests that short-term momentum is weakening. The absence of strong RSI signals and mixed volume trends indicate uncertainty, while daily moving averages provide some support.

Long-term investors may find comfort in the stock’s strong one- and three-year returns, but the recent downgrade to a Sell rating and the technical signals advise prudence. The stock’s volatility and sector-specific risks warrant close monitoring of price action and technical indicators in the coming weeks.

In summary, while Viyash Scientific retains some longer-term strength, the current technical landscape points to a cautious stance, with potential for further downside or consolidation before any sustained recovery.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read